Search Results - "Muryan, A"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Increased urinary CD80 excretion and podocyturia in Fabry disease by Trimarchi, H, Canzonieri, R, Schiel, A, Costales-Collaguazo, C, Politei, J, Stern, A, Paulero, M, Rengel, T, Andrews, J, Forrester, M, Lombi, M, Pomeranz, V, Iriarte, R, Muryan, A, Zotta, E, Sanchez-Niño, M D, Ortiz, A

    Published in Journal of translational medicine (13-10-2016)
    “…Certain glomerulopathies are associated with increased levels of CD80 (B7-1). We measured the urinary excretion of CD80, podocyturia and proteinuria in…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Podocyturia: A Clue for the Rational Use of Amiloride in Alport Renal Disease by Lombi, Fernando, Pomeranz, Vanesa, Iriarte, Romina, Zotta, Elsa, Rengel, T., Andrews, J., Paulero, M., Araoz, A., Schiel, A., Muryan, A., Canzonieri, R., Trimarchi, Hernán, Forrester, Mariano

    Published in Case reports in nephrology (01-01-2016)
    “…No specific or efficient treatment exists for Alport syndrome, an X-linked hereditary disease caused by mutations in collagen type IV, a crucial component of…”
    Get full text
    Journal Article
  4. 4

    Copious Podocyturia without Proteinuria and with Normal Renal Function in a Young Adult with Fabry Disease by Pomeranz, Vanesa, Rengel, T., Zotta, E., Lombi, Fernando, Karl, A., Forrester, Mariano, Araoz, A., Schiel, A., Muryan, A., Canzonieri, R., Trimarchi, Hernán, Andrews, J.

    Published in Case reports in nephrology (01-01-2015)
    “…The time for starting a patient with Fabry disease on enzyme replacement therapy is still a matter of debate, particularly when no overt classical clinical…”
    Get full text
    Journal Article
  5. 5

    Plasminogen activator inhibitor-1 activity and 4G/5G polymorphism in hemodialysis by Trimarchi, H, Duboscq, C, Genoud, V, Lombi, F, Muryan, A, Young, P, Schwab, M, Castanon, M, Rodriguez-Reimundes, E, Forrester, M, Pereyra, H, Campolo-Girard, V, Seminario, O, Alonso, M, Kordich, L

    Published in The journal of vascular access (01-04-2008)
    “…Chronic insufficiency alters homeostasis, in part due to endothelial inflammation. Plasminogen activator inhibitor-1 (PAI-1) is increased in renal disease,…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Proteinuria: an ignored marker of inflammation and cardiovascular disease in chronic hemodialysis by Trimarchi, Hernán, Muryan, Alexis, Dicugno, Mariana, Young, Pablo, Forrester, Mariano, Lombi, Fernando, Pomeranz, Vanesa, Iriarte, Romina, Raña, María Soledad, Alonso, Mirta

    “…Cardiovascular disease is the leading cause of morbidity and mortality in hemodialysis (HD) patients, the main etiologies being diabetes and hypertension…”
    Get full text
    Journal Article
  9. 9

    In hemodialysis, adiponectin, and pro-brain natriuretic peptide levels may be subjected to variations in body mass index by TRIMARCHI, Hernan, MURYAN, Alexis, DICUGNO, Mariana, FORRESTER, Mariano, LOMBI, Fernando, YOUNG, Pablo, POMERANZ, Vanesa, IRIARTE, Romina, BARUCCA, Nanci, CAMPOLO-GIRARD, Vicente, ALONSO, Mirta, LINDHOLM, Bengt

    Published in Hemodialysis international (01-10-2011)
    “…Adiponectin exerts cardiovascular protective actions, although some studies have shown the opposite. In hemodialysis, obese subjects display lower mortality…”
    Get full text
    Journal Article
  10. 10

    Proteinuria and its relation to diverse biomarkers and body mass index in chronic hemodialysis by Trimarchi, Hernán, Muryan, Alexis, Raña, María-Soledad, Paggi, Pedro, Lombi, Fernando, Forrester, Mariano, Pomeranz, Vanesa, Karl, Alejandra, Alonso, Mirta, Young, Pablo, Dicugno, Mariana

    “…Certain adipokines exert direct effects on proteinuria, a cardiovascular risk factor ignored in hemodialysis. We measured different adipokines according to…”
    Get full text
    Journal Article
  11. 11
  12. 12